McKesson Corporation (MCK)
| Market Cap | 87.43B |
| Revenue (ttm) | 344.58B |
| Net Income (ttm) | 2.83B |
| Shares Out | 125.33M |
| EPS (ttm) | 21.82 |
| PE Ratio | 31.92 |
| Forward PE | 19.12 |
| Dividend | $2.84 (0.41%) |
| Ex-Dividend Date | Mar 3, 2025 |
| Volume | 28,627 |
| Open | 692.59 |
| Previous Close | 695.00 |
| Day's Range | 692.59 - 699.92 |
| 52-Week Range | 464.42 - 728.32 |
| Beta | 0.49 |
| Analysts | Strong Buy |
| Price Target | 671.46 (-3.75%) |
| Earnings Date | May 8, 2025 |
About MCK
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also offers practice management, technology, clinical support, and business solutions to community-based oncology and other specialty ... [Read more]
Financial Performance
In 2023, McKesson's revenue was $308.95 billion, an increase of 11.65% compared to the previous year's $276.71 billion. Earnings were $3.00 billion, a decrease of -15.67%.
Financial StatementsAnalyst Forecast
According to 13 analysts, the average rating for MCK stock is "Strong Buy." The 12-month stock price forecast is $671.46, which is a decrease of -3.75% from the latest price.
News
McKesson Shares Rise Nearly 1% After Key Signal
MCK moves higher through the session after Alert
McKesson Unveils Precision Care Companion, Revolutionizing Precision Medicine in Community Oncology
IRVING, Texas--(BUSINESS WIRE)--McKesson launched an initiative addressing the clinical challenges and administrative burden practices face in the era of biomarker-directed care.
These 20 stocks have risen during Trump's trade tirade. Analysts see up to 30% additional upside.
The stock market doesn't react well to uncertainty. And the daily headlines about new tariffs being placed on U.S. imports and possible negotiations with trading partners to do away with tariffs have ...
Registration Opens for Annual McKesson ideaShare Conference
IRVING, Texas--(BUSINESS WIRE)--Register to attend McKesson ideaShare, a premier community pharmacy annual education and networking event, in Nashville from July 10-13, 2025.
Sit Out The Crash With These 5 Dividend Stocks
Stocks plummeted by more than 10% last week after President Trump unveiled his new ‘reciprocal' tariff chart, with some heavy importers like Kohl's, Five Below, and Wayfair falling more than 20% on th...
3 Nearly Trump-Proof Stocks Defying Trump's Tariff Shock
The S&P 500's three top performers in 2025 boast characteristics that could help them weather a further sell off.
McKesson Shares Up Over 2% After Key Signal
MCK IS UP OVER 14 POINTS AFTER THE TRADEPULSE ALERT
McKesson Gets Drugs to Patients. Buy the Stock for Healthy Returns.
An aging U.S. population is increasing the demand for medication, and this company delivers.
McKesson Corporation Completes Acquisition of PRISM Vision Holdings, LLC
IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE: MCK) today announced the completion of its previously announced acquisition of a controlling interest in PRISM Vision Holdings, LLC, a leadi...
McKesson: Immune To Weak Economy And Tariffs; Top Idea In 2025
I maintain a 'Strong Buy' rating on McKesson with a fair value of $723 per share due to its robust oncology network and strong growth prospects. McKesson's minimal exposure to US-Mexico-Canada tariffs...
Trade Tracker: Joe Terranova buys Interactive Brokers and McKesson, sells CVS
Joe Terranova, Senior Managing Director for Virtus Investment Partners, joins CNBC's "Halftime Report" to detail his latest portfolio moves.
McKesson Keeps Growing, Eyeing Bigger Future
Health care product distributor McKesson Corporation (MCK) reports big earnings gains, eye care acquisition.
McKesson Corporation (MCK) TD Cowen 45th Annual Healthcare Conference Transcript
McKesson Corporation (NYSE:MCK) TD Cowen 45th Annual Healthcare Conference Call March 4, 2025 9:50 AM ET Company Participants Britt Vitalone – Executive Vice President and Chief Financial Officer Con...
McKesson Corporation (MCK) Q3 2025 Earnings Call Transcript
McKesson Corporation. (NYSE:MCK) Q3 2025 Earnings Conference Call February 5, 2025 4:30 PM ET Company Participants Rachel Rodriguez - VP of Investor Relations Brian Tyler - Chief Executive Officer Br...
McKesson misses third-quarter revenue estimates
Drug distributor McKesson missed estimates for third-quarter revenue on Wednesday, hurt by less-than-expected sales in its U.S. pharmaceutical segment, which includes branded and specialty drugs.
McKesson Corporation Reports Fiscal 2025 Third Quarter Results and Raises Full Year Adjusted EPS Guidance
IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE: MCK) has released its fiscal 2025 third quarter financial results. Results can be accessed on McKesson's Investor Relations website at inves...
McKesson Advances Specialty Leadership; Signs Agreement to Acquire Controlling Interest in PRISM Vision Holdings, LLC
IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE: MCK) announced today that it signed a definitive agreement to acquire a controlling interest in PRISM Vision Holdings, LLC (PRISM Vision), a...
McKesson Corporation Declares Quarterly Dividend
IRVING, Texas--(BUSINESS WIRE)--The Board of Directors of McKesson Corporation (NYSE:MCK) yesterday declared a regular dividend of 71 cents per share of common stock. The dividend will be payable on A...
McKesson's Practice Insights Selected as a 2025 Qualified Clinical Data Registry by Centers for Medicare & Medicaid Services
IRVING, Texas--(BUSINESS WIRE)--For the ninth year, CMS has named McKesson a Qualified Clinical Data Registry approved to participate in the Merit-based Incentive Payment System.
McKesson Amplify Empowers State Pharmacy Associations Nationwide with Advocacy Funding
IRVING, Texas--(BUSINESS WIRE)--McKesson Amplify is intended to help protect critical pharmacy services and elevate the profession by strengthening the voice of the industry.
McKesson Corporation Completes Divestiture of Canada-Based Rexall and Well.ca Businesses
IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE: MCK) reported today that on December 30, 2024 it has closed the transaction announced in September 2024 to sell its Canada-based Rexall and ...
McKesson Corporation Announces Third Quarter Fiscal 2025 Earnings Release Date and Participation in January Conference
IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE: MCK) will release its third quarter fiscal 2025 financial results after market close on Wednesday, February 5, 2025. The company will host a...
12 High-Yield Dividend Aristocrats To Weather The Coming 2025 Storm In Style
The S&P is up almost 28% in 2024, and many investors worry about a melt-up followed by a sharp correction like in 2022 or 2018. A 2025 market correction is likely, but low-volatility, high-yield Divid...
McKesson Corporation (MCK) Annual Evercore ISI HealthCONx Healthcare Conference (Transcript)
McKesson Corporation (NYSE:MCK) Annual Evercore ISI HealthCONx Healthcare Conference December 4, 2024 8:20 AM ET Company Participants Britt Vitalone - Executive Vice President and Chief Financial Off...